Compare CVS Health Corp (CVS) vs Roblox Corp (RBLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Roblox Corp — how do they compare? CVS Health Corp trades at $94.05 (market cap $119.58B), while Roblox Corp trades at $35.27 (market cap $25.87B). The key difference: CVS Health Corp is far larger — about 4.6× Roblox Corp's market cap, and CVS Health Corp pays a 2.84% dividend while Roblox Corp pays none. Which is the better fit depends on your goals.
| CVS | RBLX | |
|---|---|---|
Market Cap | $119.58B | $25.87B |
Sector | Health | Media |
52-Week High | $110.60 | $141.56 |
52-Week Low | $65.51 | $35.60 |
Enterprise Value | $181.93B | $24.70B |
Dividend Yield | 2.84% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.67, down slightly by 0.03% today. The stock shows strong fundamental momentum with recent quarterly earnings beats, including Q2 2026 EPS of $2.58 versus $1.87 expected, and raised 2026 guidance. Valuation metrics appear reasonable with a P/E of 24.67 and P/S of 0.29. Technical indicators are mixed with a bullish overall signal but bearish moving averages, with key support at $95 and resistance at $96.
The outlook for CVS is positive, supported by earnings strength and analyst consensus, but risks include margin pressure and rising debt levels. The consensus price target of $115.90 implies significant upside, though investors should monitor execution on guidance and healthcare regulatory changes.
Roblox (RBLX) trades at $37.05, down 1.96% amid a bearish technical signal and negative net income. Revenue growth remains strong, reaching $4.89B in 2025, but profitability is elusive with a -17.61% net margin. The stock faces headwinds from multiple class-action lawsuits announced in early August 2026, creating significant legal overhangs. Analyst consensus is mixed with a $45.67 price target, suggesting potential upside if operational improvements materialize.
The outlook hinges on Roblox's ability to translate robust user engagement into sustained profitability. Near-term risks from litigation and high valuation multiples (P/S 4.51, P/B 170.23) pressure the stock, but consistent revenue growth and a bullish oscillator signal offer a contrarian opportunity for long-term investors willing to tolerate volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Roblox Corp
Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →
